US Patent Issued to Replimune on July 21 for "Treatment using oncolytic virus" (British Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,767, issued on July 21, was assigned to Replimune Ltd. (Oxfordshire, Great Britain).

"Treatment using oncolytic virus" was invented by Robert Stuart Coffin (Oxfordshire, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "An oncolytic virus for use in a method of treating or preventing cutaneous squamous cell carcinoma (CSCC), renal cell carcinoma (RCC), non-small cell lung cancer (NSCLC), triple negative breast cancer (TNBC), small cell lung cancer (SCLC), advanced recurrent head and neck cancer, squamous cell carcinoma of the head and neck (SCCHN), nasopharyngeal carcinoma (NPC), hepatocellular carcinoma (HCC), anal cancer, colorectal can...